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INTRODUCTION 
Rhodanese (E.C. 2.8.1.1, thiosulfate:cyanide sulfur transferase) 
is a mitochondrial enzyme which catalyzes the conversion of cyanide ion 
into thiocyanate. The overall reaction, with thiosulfate as sulfur donor, 
is as follows: 
+ s 0::::: 2 3 
cyanide + thiosulfate 
rhodanese so::: 3 + SCN 
sulfite + thiocyanate 
Because of its ability to catalyze the detoxification of cyanide, 
rhodanese plays a critical role in the mechanism of action of the pro-
posed anti-cancer drug laetrile, as postulated by Krebs (1970). Accord-
ing to the Krebs hypothesis, when laetrile enters the body, much of it 
is excreted unchanged. However, a fraction of it is hydrolyzed by the 
lysosomal enzyme beta-glucosidase into three products as follows: 
N ,....\-\ 6('0-~o-e beta-glucosidase 
~ ::;::::>" 
laetrile + water 
5 HCN 
I 
benzaldehyde + glucose + hydrocyanic acid 
When the HCN is released, rhodanese is thought to act upon the HCN, de-
toxifying it before it is able to inhibit aerobic respiration. 
2 
Krebs has hypothesized that beta-glucosidase is present in all 
tissues of the body. Rhodanese activity, however, is proposed to be 
present only in normal body tissues. This is because Krebs has proposed 
that neoplastic tissue produces chorionic gonadotropin, which he states 
inhibits the rhodanese activity in this tissue (1977). Neoplastic tis-
sue, therefore, lacks rhodanese activity. As a result, Krebs believes 
that when laetrile contacts the neoplastic tissue, the beta-glucosidase 
present catalyzes the production of HCN, which the cancer cells are then 
unable to act upon because they lack r?odanese. v~oplastic tissue, 
therefore, is selectively attacked by laetrile. 
In order to test the Krebs hypothesis, the presence of rhodanese 
in neoplastic tissue was investigated. Selected tissues in tumor-
bearing mice as well as the corresponding tissues in normal control 
mice were also studied for rhodanese activity. These tissues were then 
compared to each other and to neoplastic tissue for significant differ-
ences in rhodanese activity levels. 
This paper presents the results of these investigations and a 
discussion of the findings as they relate to the Krebs hypothesis. 
REVIEW OF THE LITERATURE 
In 1933 Konrad Lang first discovered an enzyme in animal tiss~e 
capable of converting colloidal sulfur or thiosulfate and cyanide to 
thiocyanate. He called this enzyme rhodanese because it synthesizes 
rhodanate (thiocyanate). He determined that the reaction proceeded 
according to the following equation; 
+ 
7 
+ w= 3 
Lang used a colorimetric assay technique and surveyed a substantial 
number of mammalian, avian, and frog tissues for rhodanese activity. 
He was also able to effect a 20-fold purification of oeef-liver 
rhodanese. 
Rhodanese has been the subject of much investigation since 
Lang's original work, and the specific action of rhodanese can now be 
described as follows: 
free rhodanese + sulfane-containing anion 
sulfur-substituted rhodanese + thiophilic anion 
(Westley, 1973) 
Free rhodanese molecules react with sulfane-containing anions to form 
the sulfur-substituted rhodanese which, in turn, reacts with highly 
thiophilic anions to transfer a sulfur atom. 
3 
4 
For twenty years it was generally believed that rhodanese was 
specific for thiosulfate and cyanide as substrates. Then in 1953 
Sorbo investigated the possibility of other sulfur-containing com-
pounds serving as sulfur donors. He concluded that rhodanese can 
utilize thiosulfonates that contain a . free thiol group. For example, 
s-so2-o 
thiosulfate p-toluene 
thiosulfonate 
ethyl thiosulfonate 
(Sorbo, 1953) 
') 
Thiosulfate and para-toluene thiosulfonate both contain free thiol 
groups, but since ethyl thiosulfonate does not, it cannot serve as a 
substrate. Sorbo showed that thiosulfonates of the form: 
0 
ll 
R---s----s 
II 
0 
can serve with cyanide as a sulfur donor (19531.. He also demonstrated 
that, 
The activity of the thiosulfonate is roughly correlated to 
the electropositivity of the radical attached to the hexa-
valent sulfur atom, as the activity is increased when the 
hydroxyl group in the thiosulfate is replaced by an aromatic 
radical and further increased when instead an aliphatic radi-
cal is introduced. (Sorbo, 1953} 
Parker and Kharasch (19591 have shown that compounds containing 
at least one sulfur-sulfur bond at the sulfenyl (-S-) level of oxida-
tion are suitable as sulfur-donor substrates of rhodanese as long as 
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the donor sulfur atom is not bonded to atoms other than sulfur of 
hydrogen. With this requirement met, polysulfides, persulfides, thio-
sulfonates and thiosulfate can all serve as sulfur-donor substrates 
(Westley, 1973). 
In a sophisticated series of articles by Westley and his co-
workers from 1961 to 1974, the mechanism of action of rhodanese was 
investigated and described. They demonstrated that the rhodanese re-
.. ~tion proceeds via a double displacement mechanism in which the enter-
~tt ~ . 
ing nucleophile and the leaving group ' are aligned on opposite sides of 
the transferred sulfur atom. Optimum pH is 8.6. 
Enzyme + 2 sso3 ,1 ___ 7, Enzyme-s2 + 
Enzyme-s2 + 
2 CN -.L./ ___ 7.., Enzyme + 2 SCN-
(Green and Westley, 1965) 
From their findings they concluded that a cationic binding site (Mintel 
and Westley, 1966) and a hydrophobic region composed of seven amino 
acids of cysteinyl and tryptophanyl residues were present at the active 
site (DeToma and ~'lestley, 1970), They demonstrated that the sulfur-
sulfur bond cleavage is facilitated by a shift of electrons away from 
the planetary sulfur atom, thereby creating a nucleophilic center on the 
sulfur-donor compound (Mintel and Westley, 1966). This explained the 
importance of the cationic or nucleophilic residue at the active site of 
rhodanese. Schlesinger and Westley have concluded (19741 that when 
rhodanese and thiosulfate interact, they form a complex that results in 
charge neutralization and a shift of electrons away from the planetary 
6 
sulfur on the thiosulfate. The resulting sulfite is then displaced by 
the enzymic nucleophilic group. This is the rate-limiting step. (Mintel 
and Westley, 1960.) Apparently the displacing nucleophile is the sulf-
hydryl group on the essential cysteine (Schlesinger and Westley, 1974). 
The sulfur-substituted rhodanese then reacts rapidly with the thiophilic 
anion acceptor (eg. cyanide) and forms the product (eg. thiocyanate) and 
the free enzyme. The sulfur-substituted enzyme can also react with 
thiocyanate to form an unreactive "dead end" complex (Volini and Westley, 
1966}. 
Sulfur-acceptor substrates have been studied by several workers 
including Koj (19681, and others CVillarejo and Westley, 1963, Mintel 
and Westley, 1966} 1 The sulfur-acceptor substrates have been widely 
accepted to follow a thiophilicity series rnucleophilicity for sulfur} 
according to reactivity. It can be seen that how well the attacking 
nucleophile can polarize determines the reaction properties. A typical 
thiophilicity series is as follows: 
(Westley, 1973)_ 
Rhodanese has also been observed to catalyze the reduction of thio-
sulfate to sulfite using borohydride, dihydrolipoate, cysteine, and 
glutathione with the relative activity decreasing in the order given, 
with none being as reactive as cyanide (Koj, 1968). Alkyl and aryl 
sulfinates (RS02) were later found to be active acceptor substrates 
7 
(Sorbo, 1962). Apparently nearly any thiosulfonate-sulfinite pair can 
function as rhodanese substrates. A few exceptions do exist, however. 
Volini and Westley found that: 
Dithiols which oxidize to cyclic disulfides having more than 
five ring members (i.e., larger than the dithiolane ring of 
oxidized lipoate) do not seem to be active substrates. Both 
dithiothreitol and dithioerythrytol fail to yield measureable 
rates. In fact, both of these compounds rapidly inactivate 
rhodanese. 
(Westley, 1973) 
Other compounds have also been determined to be inhibitors or 
inactivators of rhodanese and have been extremely important in deter-
mining the structure of the active site. In Lang's original article 
(1933)_ he describes the inhibiting effect of divalent cations. Late:t: 
Saunders and Himwich (1950} studied their effect in detail and showed 
that cu++ and Fe++ are strong inhibitors but that others, including 
Mn++ , Si++ , ca++ , Li++ , Mg++ , and Ba++ have little or no effect. 
They also demonstrated the inhibiting effects of sodium sulfide, 
cysteine, and iodoacetate. The inhibitory effects of CN- were also 
studied independently by Sorbo (19621. CN and so3 
= 
can markedly in-
hibit rhodanese activity, but in the presence of cysteine or thiosul-
fate, inhibition is prevented. Sorbo (19531 also showed that thio-
cyanate, too, can inhibit rhodanese activity if it is in too high of a 
concentration. However, thiosulfate has been shown to significantly 
' 
reduce the sensitivity of rhodanese to many inactivating and inhibiting 
reagents. But this sensitivity also depends upon other factors, includ-
ing oxygen and protein concentrations (Westley, 1973}. Dithiothreitol 
8 
causes complete inactivation of rhodanese. Kim and Horowitz (1975)_ 
suggest that it binds to the essential sulfhydryl group. Dinitrobenzene 
(Volini and Wang, 1973), N-ethylmaleimide, and mercuribenzoate are in-
hibitors first described by Sate and Hayashi (1952}. Since then, other 
thiol-directing reagents have been shown to inhibit rhodanese function. 
When a mixed disulfide is produced by the oxidation or alkylation of one 
of the sulfhydryl groups, rhodanese is inactivated. Wang and Volini 
(1968) used this line of investigation to demonstrate the importance of 
the sulfhydryl groups for catalysis. Their evidence also suggests that 
since a rather high concentration of anions, aromatic nitro compounds, 
and aliphatic mercaptans inhibit rhodanese activity, one of the essential 
groups at the rhodane~e active site is aromatic. rn 1976 B~illie and 
Horowitz concluded that tryptophan residues are essential for activity 
from their kinetic inhibition studies using N-1-4-pyridyl-pyridium 
chloride, N-methyl-nicotinamide chloride, and nicotinamide. 
As a result of these studies employing inhibiting and inactivat-
ing agents, Westley (1973) has postulated the presence of three essen-
tial parts of the rhodanese active site. These are a sulfhydryl group, 
a cationic group, and a hydrophobic area. Wang and Volini (1968) con-
cluded that these groups are close to one another spatially, "since 
blocking with either a thiosulfate-competitive anion or a thiosulfate-
competitive aromatic protects the essential sulfhydryl group from attack, 
as does blocking with thiosulfate or with just the transferable sulfane 
sulfur itself." (Westley, 19731 
9 
Other characteristics of the enzyme have been elucidated includ-
ing recently, its complete amino acid sequence. Sorbo (1953} was the 
first to crystallize rhodanese and determine its molecular weight, 
approximately 37,000. Its optimum pH has been widely accepted to be 
approximately 8.6. No prosthetic groups have ever been discovered 
(Westley, 1973}_, Several investigators including Volini, et al. (1967}, 
and Bolen and Rajender (1974) have tried to determine whether a zinc ion 
is bound to rhodanese and is necessary for either structural integrity 
or catalytic activity. It is especially difficult to draw any conclu-
sions because all the substrates complex with metal ions except the 
thiosulfonates and because of the obvious difficulty of ridding all 
glassware, solutions, etc. from trace ions. Bolen and ~jender concluded 
that, "commercial rhodanese binds zn++ with moderate to weak affinity by 
a process that is entropy driven." 
In the last several years much sequence analysis of the active 
site has been done. DeToma and Westley (19701, Blumenthal and Heinrikson 
(19721, and Cannella, et al. (1973L have independently determined the 
amino acid s.equence around the reactive cysteinyl residue of rhodanese. 
Concurrently, Heinrikson and Russell (19721 published their findings on 
the sequence analysis of the tryptic peptides containing tryptophan. 
During this time, however, a controversy had arisen concerning the 
molecular weight of rhodanese. 'A mobile monomer-dimer equilibrium 
(Volini, DeToma and Westley, 196 7 L was proposed and subsequently con-
firmed by Horowitz and Westley (1970}. The monomer was suggested to 
have a molecular weight of 19,000, to be identical subunits, to have 
one active site, and to aggregate in a pH-dependent reaction into the 
10 
dimer by a disulfide bond between the nonactive site crysteines. They 
maintained that dissociation of the monomers occurs at a high pH, while 
at a pH of 7 a stable dimer-monomer equilibrium exists. In the last two 
years, however, Ellis and Woodward (19751, Bergsma, Hol, et al. (1975), 
Russell, Weng et al. (1975), and Crawford and Horowitz (1976) have inde-
pendently done extensive investigations resulting in data inconsistent 
with the presence of any monomeric species. Their evidence appears to 
have been accepted. 
Finally, the complete sequence analysis of rhodanese has recently 
been worked out (Russell, Weng, et al., 1975). This evidence indicates 
that rhodanese is a single polypeptide of molecular weight 35,200. 
The biological distribution of rhodanese is of major imJ?ortance 
to this investigation. Lang (1933l found rhodanese present in birds, 
frogs, E. coli, and in all mammalian tissues investigated except blood 
and muscle. He demonstrated the wide variety of activity levels of rho-
danese among various tissues. 
Gemeinhardt U939) first determined rhodanese activity in plants, 
and others later followed. Tomati, ~ al. (19721 recently detected low 
levels of activity in the chloroJ?lasts of spinach, turnips, parsley, and 
cabbage. Himwich and Saunders (19501 studied a wide variety of mammalian 
tissues. The results correlated well with Lang's, but Himwich reported 
low levels of rhodanese in muscle tissue. Sorbo (1951) also reported 
rhodanese activity in a wide variety of tissues, and his results confirmed 
the earlier reports. F;rom these investigations, the liver and adrenal 
glands appear to have the highest levels of activity, with moderately 
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high levels appearing in the kidneys, and lower levels in other tissues. 
In 1955, deDuve, Pressman, et al. studied the subcellular distribution 
of rhodanese and reported the enzyme to be confined exclusively to the 
mitochondrion. In 1975, Koj, et al. investigated not only the intra-
cellular but the intrarnitochondrial activities of rhodanese, in rodent 
liver, and the results were as follows, with mean rhodanese activity 
expressed as micromoles seN- formed during five minutes incubation at 
whole homogenate = 9.25 
nuclear fraction = 15.31 
mitochondrial fraction = 22.23 
lysosomal fraction == 5.57 
microsomal fraction = 0.29 
final supernatant = 0.95 
For the intrarnitochondrial fraction: 
outer membrane = 163 = 2,3% 
inner membrane = 117 = 1.6% 
interrnembrane ;::: 969 = 13.3% 
matrix = 6021 = 82.8% 
(Koj, Frendo, and Wojtczak, 1975) 
Thus, rhodanese appears to be nearly ubiquitous, but as yet, the 
primary function of the enzyme remains unknown. A role in the detoxi-
fication of cyanide was believed to be its most important function for 
12 
a long time, but this does not seem to account for the high activities 
found in the liver (Westley, 1973}. , Another possible action is the 
neutralization of the sulfide formed by cysteine degradation. 
L-cysteine cysteine " 
" desulfhydrase 
H2S + NH3 + pyruvate 
cystine + H2S + so3 rhodanese 
........ 
(Koj, Frendo, 19621 
Koj and Frendo (1962)_ measured activities of rhodanese and cysteine 
desulfhydrase in various tissues to investigate a possible correlation, 
but their results were inconclusive. Other possible functions include 
the transfer to reduced sulfur (.Koj, 1967} and a ,J?Ossible redox role 
CWang and Volini, 19681, but the results are also not clear. 
Krebs maintains that the major role of rhodanese is in the de-
toxification of CN- (.19701. Over thirty years ago he proposed that 
nitrilosides, commonly found in many plants, indirectly have an anti-
tumor effect. He believes that western society is experiencing an 
increasing incidence of cancer because it is a vitamin deficiency dis-
ease and man has eliminated nearly all of the nitriloside-containing 
foods from his diet. He postulates that the mechanism of action of the 
nitrilosides, particularly amygdalin, or laetrile, is as follows. 
Laetrile enters the body by foodstuffs and is hydrolyzed by the enzyme 
beta-glucosidase, a lysosomal enzyme, "produced by intestinal bacteria 
as well as by the body." (Krebs, 1970,} 
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beta-glucosidase '> 
amygdalin (or laetrile) + water 00 lq 
benzaldehyde + glucose 
HCN 
+ hydrocyanic acid 
Accordingly, the released HCN is then detoxified by rhodanese to form 
thiocyanate. Krebs maintains that all normal tissues of the body pro-
duce rhodanese, but neoplastic tissue does not exhibit rhodanese activ-
ity because of the inhibiting effects of chorionic gonadotropin produced 
by the neoplastic tissue (Krebs, 19771, As a result, it is selectively 
attacked by the CN- • 
In 1952 Gal, et ~ measured rhodanese activities in various 
normal tissues and cancerous ones of mice and rats. They concluded 
that, "The tumors do not have less rhodanese content than their homolo-
gous tissues_ or of some of the vital organs." 
Because of the significance of these findings, however, a re-
investigation of rhodanese activity in normal and tumorous tissues is 
indicated, and has been undertaken. 
MATERIALS AND METHODS 
I. Animal Model and Care 
Five-week old male mice, strain BALB/cJ (Jackson Laboratory, Bar 
Harbor, Maine) were the animals used throughout this investigation. 
Because of the unusual aggressiveness of the males, animals were 
maintained in separate false-bottom cages which were properly labeled. 
t 
They received Purina Standard Mouse Chow and tap water ad libitum. Humid-
ity in the animal room varied between 35%-55%, temperature varied between 
69 -74° F, the photoperiod was twelve hours of light and twelve hours of 
darkness, and soft background music was played continuously. 
II. Tumor Transplant Technique 
The tumor, an axillary sarcoma, #sl80 (Jackson Laboratory) arose 
spontaneously in a white mouse in 1914 in the Croker Laboratory at 
Columbia University. It was isolated and has been used for transplanta-
tion ever since. 
The tumor transplant technique is a modification of the procedures 
·described by Jackson Laboratory (1975} and I. J. Fidler, et al. (1974). 
All equipment was sterile, and aseptic technique was observed. 
The tumor donor animal was killed by cervical dislocation and the 
tumor immediately ;removed. Note, the tumor from one donor animal was 
adequate for the transplantation procedure. All skin, muscle, and 
14 
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necrotic tissues were separated and the neoplastic tissue placed into a 
Petri dish containing cold, sterile, mouse Ringer's solution (Locke's 
solution: 9.0 g NaCl, 0.2 g cac12 (anhydrous), 0.2 g NaHC03 , 2.5 g 
glucose, and 0.4 g KCl per liter of solution), The neoplastic tissue 
was then pressed through a 50-mesh tissue sieve with a glass pestle. As 
the droplets fell from the sieve they were collected in the bottom half 
of a Petri dish containing 5.0 ml. chilled, sterile, mouse Ringer's 
solution. The resultant cloudy red suspension was mixed by swirling, 
placed on ice and covered with the top half of the Petri dish. Each 
recipient mouse was fully anesthetized individually with ether, placed 
ventral side up, and the upper and lower right quadrants swabbed with a 
sterile alcohol sponge. Q.S ml. o;l; the tumor cell suspension was then 
injected subcutaneously with a 22 gauge, 1-1/2" needle into the right 
axillary region. Control animals were similarly anesthetized and in-
jected with 0.5 ml. of sterile, chilled, mouse Ringer's solution. 
During each tumor transplantation there were nine experimental animals 
(receiyed the suspended tumor cellsL and six control animals (received 
the Ringerls solution}, In this fashion from each transplantation three 
experimental animals were used to maintain the tumor and the six controls 
and the six experimentals were used in the rhodanese studies. 
After the tumor transplant, instruments and equipment were soaked 
in Benz-all, an anti-rust, antiseptic agent (Xttriua Laboratory, Chicago, 
Illinoisl, scrubbed with soap, rinsed twelve times in tap water, ten 
times in distilled water, and six times in distilled deionized water, 
then autoclaved. Needles and syringes were discarded, 
16 
III. Tissue Isolation and Homogenization 
Materials and reagents are listed in Table I in the Appendix. 
Each mouse was killed by cervical dislocation. The tissues were 
rapidly removed and placed in 5.0·ml. ·of 4° C Tris-HCl buffer, pH 7.4. 
During the dissection the body cavity was bathed in cold mouse Ringer's 
solution. Four whole brains, four kidneys, one liver, and the back, 
thigh, and leg muscles from three animals were pooled for each respec-
tive tissue assay. Only neoplastic tissue was used for the tumor tissue 
assay; however, the number of tumors used for each assay varied between 
four to seven depending upon the mass of the neoplasms. 
After isolation, all tissues except the muscle were homogenized 
with three up and down strokes in the 5. 0 ml. of cold Tris buffer. The 
muscle tissue was first minced into small pieces which were homogenized 
individually in 5.0. ml. of 4° C Tris buffer. This modification yielded 
complete homogenization. 
Tissues were next transferred to chilled centrifuge tubes and 
spun at 20,200 X g. for ten minutes. The supernatant was transferred to 
, 
a 20 cc. chilled vial, capped, quick-frozen with Cryokwick spray, and 
stored frozen. Within three weeks the supernatant prepared above was 
analyzed for rhodanese activity. 
IV. Protein Assay 
Protein was determined according to the Lowry technique (1951). 
See the Appendix under Protein Assay for the procedure, materials and . 
reagents, standard curve, and calculations. 
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V. Enzyme Assay 
This technique is a modification of the procedure described by 
Bo H. Sorbo (1953) , Table III in the Appendix lists the solutions in-
cluding standards and the equipment necessary for the assay. 
The following reagents were added to each of seven reaction 
vessels: 0.25 ml. of 9.2 M NaH2Po4 , 0.5 ml. of 0.125 M sodium thio-
sulfate, and 0.25 ml. of 0.25 M sodium cyanide. All seven vessels were 
then placed in a 30° C water bath and incubated for ten minutes. At 
staggered time intervals CO, 1, 2, 4, 8, and 16 min.) , 0. 25 ml. of the 
tissue supernatant (thawed to 4° C) was added, the solution vortexed, 
and the vessel placed back into the water bath. 0.25 ml. of the 1:1 
11\i.xture of 0 .. 0125 M sodium thiosulfate and 0. 025% serum bovine albumin 
was substituted for the enzyme solution in the blank. Final pH in this 
reaction mixture was 8.6. At the end of the appropriate time interval, 
the reaction was stopped by the addition of 0.25 ml. of 38% formaldehyde. 
'lbe reaction vessel was once again returned to the water bath. For the 
"O min." the formaldehyde was added to the reaction vessel before the 
tissue supernatant. After all reactions were complete, the vessels were 
removed from the water bath. Ferric nitrate reagent, 1,25 ml., then 
12.5 ml. of water were added to each vessel. These were mixed, trans-
ferred to centrifuge tubes, and spun at 20,200 X g. for 15 minutes to 
remove any precipitate. The percent transmission at 460 nm was then 
read and recorded for each. 
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The nine crude tissue supernatants (control mouse liver, kidney, 
muscle, and brain; and tumor-bearing mouse liver, kidney, muscle, brain, 
and tumor) were assayed for rhodanese activity. Five different samples 
of each tissue type were assayed using the six incubation times (0, 1, 
2, 4, B, and 16 min.) plus a blank for each assay. The percent trans-
mission for each of these seven reaction vessels was recorded. 
For the standard curve, 0.75 ml. of the given standard solution 
was added instead of 0.5 ml. of 0.0125 M sodium thiosulfate and 0.25 ml. 
of 0.25 M sodium cyanide. After three assays were performed, new solu-
tions were prepared and used for the last two assays, as was done in the 
preparation of the protein standard curve. The results between the two 
sets of data were then compared :!;or any possible computation or solution 
preparation error. 
All data obtained were subjected to statistical analysis. An ex-
planation of; the statistical analysis, as well as sample data, and 
sample calculations are given in the Appendix under "Tissue Assay 
Calculations for :Rhodanese and Protein." 
'· 
EXPERIMENTAL DATA 
I. Tumor Transplant 
Three days after transplantation tumors were palpable, and 
continued to grow until the animal was sacrificed (11 - 16 days) for 
the study or expired (25 - 40 days) . No control animals developed com-
parable tumors. 
Histological sections stained with hematoxylin and eosin were 
examined by Dr. J, Carter, M,D., pathologist (Louis A. Weiss Memorial 
Hospital, Chicago, Illinoisl , He confirmed the malignancy of the tumor 
and identified it as a histiocytic lymphosarcoma. 
II. Rhodanese Activity Curves for.Each Tissue 
Linear regression was performed on the data for each tissue in 
order to determine the linearity of the data and the best fit line for 
each tissue. Figures I - V each represent one tissue type studied from 
the control and tumor-bearing animals, and show the graph of rhodanese 
activity. Note, the values for the zero-minute readings were subtracted 
.from all values as a correction for non-specific catalysis of cyanide to 
thiocyanate. The standard error or standard deviation obtained for each 
data point is also plotted. 
One unit of rhodanese activity is defined as one micromole of 
thiocyanate formed per mg protein. 
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III. Chi Square Analysis 
A chi square analysis was then performed in order to determine 
whether or not a significant difference in rhodanese activity existed 
between: 
1. each tumor-bearing mouse tissue and its corresponding 
control tissue 
2. the neoplastic tissue and each analyzed tumor-bearing 
mouse tissue. 
Table I lists these analyses. 
IV. Comparison of One-minute Specific Activity Values for Tissues 
Studied 
Figure VI is a bar graph comparing one-minute rhodanese specific 
activity values for the tissues investigated from normal and tumor-
bearing mice. Standard deviations are plotted for the liver tissues 
and standard error for the other tissues studied. 
FIGURE I - RHODANESE ACTIVITY CURVE FOR CONTROL AND TUMOR-BEARING 
MOUSE LIVER TISSUES 
Liver tissue had the highest rhodanese activity of all tissues 
studied. Its activity in normal. mic~ was found to be significantly 
lower (chi square = 0. 05 level) \vhen compared to that from tumor-bearing 
mice. 
On the graph, tumor-bearing mouse liver tissue is plotted with a 
dotted line and that from the normals with a solid line. 
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FIGURE I 
RHODANESE ACTIVITY CURVE FOR CONTROL 
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FIGURE li - :RHODANESE ACTIVITY CURVE FOR CONTROL AND TUMOR-BEARING 
MOUSE KIDNEY TISSUES 
Kidney tissue had moderately high rhodanese levels when compared 
. 
to the other tissues investigated. Its activity was significantly lower 
than that in liver, but significantly higher than brain, muscle, or 
neoplastic tissue activity levels. No significant difference was found 
between the activities of normal and tumor-bearing mouse kidney tissues. 
Tumor-bearing mouse kidney tissue rhodanese activity is plotted 
· • with a dotted line and that from the normals with a solid line. 
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FIGURE II 
RHODANESE ACTIVITY CURVE FOR CONTROL 
AND TUMOR-BEARING MOUSE KIDNEY TISSUES 
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FIGURE III - RHODANESE ACTIVITY CURVE FOR CONTROL AND TUMOR-BEARING 
MOUSE BRAIN TISSUES 
Brain tissue had significantly lower levels of rhodanese activity 
than kidney and liver tissues. However, the activity was equal to that 
of muscle and tumor tissues. No significant difference was found be-
tween the rhodanese activities of the control mouse brain tissue and 
that from the tumor-bearing animals. 
Tumor-bearing mouse brain tissue is plotted, with a dotted line and 
that from the normals with a solid line. 
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FIGURE III 
RHODANESE ACTIVITY CURVE FOR CONTROL 
AND TUMOR-BEARING MOUSE BRAIN TISSUES 
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FIGURE IV - RHODANESE ACTIVITY CURVE ~OR CONTROL AND TUMOR-BEARING 
MOUSE MUSCLE TISSUE 
Muscle tissue had significantly lower levels of rhodanese activity 
than kidney and liver tissues. However, the activity was equal to that 
of brain and tumor tissues. No significant difference was found between 
the rhodanese activities of the control mouse muscle tissue and that from 
the tumor-bearing animals. 
Tumor-bearing mouse muscle tissue is plotted with a dotted line 
and that from the normals with a solid line. 
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FIGURE IV· 
RHODANESE ACTIVITY CURVE FOR CONTROL 
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FIGURE V - RaODANESE ACTIVITY CURVE FOR TUMOR-BEARING MOUSE 
TUMOR TISSUE 
Neoplastic tissue had significantly lower levels of rhodanese 
activity than kidney and liver tissues. However, the activity was 
equal to that in brain and muscle tissues. 
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FIGURE V 
RHODANESE ACTIVITY CURVE FOR 
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TABLE I 
This table lists the chi square analyses of: 
A. Rhodanese activity between tumor-bearing mouse tissue and its corre-
sponding control tissue, and B. Rhodanese activity between neoplastic 
tissue and selected tumor-bearing mouse tissues. No significant differ-
ences were found when the tumor-bearing mouse kidney, muscle, and brain 
tissues were compared to their corresponding control tissues. However, 
when the liver tissue activities were compared, the liver from tumor-
bearing mice had a significantly higher activity than that in liver from 
the control animals. 
The neoplastic tissue had significantly lower activity than that 
found in liver and kidney tissues. However, its activity was not statis-
tically different from that found in brain and muscle tissue. 
TABLE I 
A. A Comparison of Rhodanese Activity Between Tumor-Bearing 
Mouse Tissue and Its corresponding Control Tissue 
Tissues compared Chi Square value Significance 
liver 3.9060 yes - 0.05 level 
kidney 3.3767 none 
brain 0.2335 none 
' ' 
muscle 0.3492 none 
B. A Comparison of Rhodanese Activity Between Neoplastic 
Tissue and Selected Tumor-Bearing Mouse Tissues 
Neoplastic Tissue Compared to: Chi Square Value Significance 
liver 43.4304 0.005 
kidney 14.8050 0.005 
brain 0.1893 none 
muscle 1.1692 none 
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FIGURE VI - A COMPARISON OF ONE-MINUTE RHODANESE SPECIFIC ACTIVITY 
VALUES FOR SELECTED TISSUES FROM NORMAL AND TUMOR-BEARING MICE 
This table summarizes the relative one-minute rhodanese specific 
activities of the tissues studied. It can be seen that liver tissue has 
the highest activity, with kidney tissues showing moderately high ac-
tivities, and the muscle, brain, and tumor tissues having lower activi-
ties that are equal to each other statistically. Note that the liver 
tissue from the tumor-bearing mouse had statistically higher activity 
than that from the control mouse. Standard deviations are plotted for 
the liver tissues and standard error for the other tissues studied. 
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FIGURE VI 
A COMPARISON OF ONE-MINUTE RHODANESE SPECIFIC ACTIVITY 
VALUES FOR SELECTED TISSUES FROM NORMAL AND TUMOR-BEARING MICE 
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DISCUSSION 
From the experimental results (see Figures I - VI}_ it can be seen 
that rhodanese has a wide range of activity among various body tissues. 
The results obtained correlated well with those of earlier studies. (Lang, 
1933, Sorbo, 1951, and Gal, Fung, and Greenberg, 1952}. Gal and his asso-
ciates assayed rhodanese activity in a spontaneous tumor (hepatoma produced 
by azo dye feeding}_ in rats, a myeloid leukemia (Bar Harbor Gl498l in rats, 
and three transplanted mouse carcinomas and one sarcoma. In all cases 
rhodanese activity was present in the tumors. They concluded that, "While 
the rhodanese content of tumors, in general, is !;>mall, j.t is by no means 
inconsequential in comparison to other metabolically active tissues." Al-
though this conclusion conflicts with the Krebs hypothesis, Gal and his 
associates also studied female rodents. Rhodanese activity in the tissues 
assayed was similar to that in males except during pregnancy. It was 
interesting to note that the enzyme activity values of liver and kidney 
in pregnant females were both lower than that found in the normal controls. 
This is consistent with the Krebs hypothesis that chorionic gonadotropin 
inhibits rhodanese activity (1977L 
Studies of the anti-tumor activity of laetrile were done by Laster 
and Schabel (19751 and Nodinsky and Swiniarski (1975}.. In both investi-
gations low concentrations of amygdalin (laetrile} were administered alone 
and in combination with beta-glucosidase. They concluded that amygdalin 
alone had no effect, but in combination with beta-glucosidase it was 
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highly toxic. A closer examination revealed that the highest dose of 
amygdalin administered was only 500 mg/kg body weight. Other.studies 
have shown (Manner, DiSanti, and Michaelson, 1977)_ that doses up to 
4000 mg/kg daily are non-toxic. Krebs maintains that high doses are 
necessary for anti-neoplastic activity (19771. 
One of the major obstacles to laetrile therapy is the proposed 
toxicity of the cyanide ion. The present investigation demonstrates the 
ubiquity of rhodanese in all tissues studied, which provides a mechanism 
for the detoxification of cyanide by conversion to thiocyanate. This 
supports the research of Atkinson, Rutter, and Sargeant (1974) in which 
rhodanese was an effective antidote for experimental cyanide poisoning. 
The :r;>resence of rhodanese activitJ' in the tumor raises questions regard-
ing the efficacy of laetrile to kill cancer cells. According to Krebs, 
it is because of a lack of rhodanese that neoplastic tissue is a direct 
target of the cyanide released from the hydrolyzed laetrile. However, 
Sorbo (19531 has shown that rhodanese is not cyanide specific and that 
most thiophilic anions serve competitively in this capacity. Another 
weak spot in the Krebs postulate is his assumption that thiosulfate is 
present as a sulfur donor. Volini, DeToma, and Westley (1966, 19671 have 
found relatively low levels of thiosulfate in vivo, while other sulfane-
containing compounds are conunonly given off in reactions involving pro-
tein metabolism. Westley (19731 has demonstrated that the enzyme com-
bines with a variety of sulfane-containing anions forming the sulfur-
substituted rhodanese. This correlates with the findings of several 
workers (Sorbo, 1962, Hintel and 't"lestley, 1966 }_ whose data assigns 
rhodanese the task of a general sulfane transferase. 
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The results of this study suggest that laetrile may not work 
by the biochemical rationale put forth by Krebs. It must be emphasized, 
however, that this data conflicts with the Krebs hypothesis only on the 
activity of rhodanese in neoplastic tissue. However, the tumor used was 
not spontaneous but transplanted. It is possible that the observed 
palliative effects of laetrile may by the result of varying beta-
glucosidase activity levels, enzyme solubilities, and relative free 
enzyme activities in vivo. 
SUMMARY 
Rhodanese activity was determined spectrophotometrically in 
supernatants from crude tissue homogenates of selected tissues iso-
lated from male mice (strain BALB/cJ, Jackson Laboratory, Bar Harbor, 
Maine) with transplanted axillary sarcomas. The control group in-
cluded male mice of the same strain injected with mouse Ringer's 
solution (Locke's solution, the vehicle). Enzyme activity was high 
in the liver, with kidney showing moderate activity, and brain and 
muscle tissues having lower activity. A significant increase in the 
activity of tumor-bearing mouse liver tissue as compared with that 
from normal controls was also noted. The tumor tissue, which has 
been postulated to be devoid of rhodanese activity, was found to ~ye 
activity equal to brain and muscle tissue. 
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TABLE I 
MATERIALS AND REAGENTS FOR THE TISSUE ISOLATION AND HOMOGENIZATION 
plastic centrifuge tubes 
refrigerated centrifuge - Sorvall S·uperspeed RC2-B - automatic 
refrigerated centrifuge (Sorvall, Inc., Newtown, Conn.) 
tissue homogenizer 
coarse forceps 
angle-edged scissors 
Buffer: 
0.158% Tris:HCl, pH= 7.6 
12.5 mmole/liter Na
2
s
2
o3 
100 mmole/liter glycine 
1 mi./liter Triton X - 100 
NOTE: All chemicals were obtained from Sigma Chemical Co., St. Louis, 
Mo. 
Cryokwick (Damon/IEC Division, Needhan Hgts., Mass.) 
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PROTEIN ASSAY 
This technique is a modification of the procedure described by 
Oliver R. Lowry, et al. (1951I, Solutions including standards and the 
equipment necessary for the assay are listed in Table II. 
3.5 ml. of Reagent C was added to 0.7 ml. of the unknown protein 
solution or standard. Water was substituted for the protein solution in 
the blank. After vortexing, this solution was allowed to stand at room 
temperature for a minimum of ten minutes. Next 0.35 ml. of Reagent E 
was added very rapidly and the solution vortexed. After a minimum of 30 
minutes, the sample was diluted with 36.4 ml. of water. The percent 
transmission was then read at 500 run in a Bausch and Lomn "spectronic 20" 
spectrophotometer and recorded. 
NOTE: When the standard curve was being prepared, three assays 
we:r:e performed, then all solutions were discarded. New solutions were 
prepared and used for the last two assays. The results between the two 
sets of data were then compared for any possible computation or solution 
preparation error. 
Figu:r:e ! is the standard curve for protein, absorbance ~ptical 
density, O.D.l vs. concentration. The points on the curve represent the 
best fit points derived by linear regression using the mean absorbance of 
each of the protein concentrations chosen. The standard deviation of the 
experimental values for each point is also shown. 
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The following is the equation of the line derived by linear 
regression. It was used to calculate all experimental protein 
concentrations. 
X = (57 .1429) Y - • 0005 
.OD12 
where 57.1429. represents the dilution factor obtained as 
follows: 
57.1429 = 5.0 (36.4) 
0.7 4.55 
5.0 
0.7 
= total supernatant volume 
= sample of supernatant volume measured 
36.4 = ml. of water added to each reaction vessel 
4.55 = total volume in reaction vessel. 
Table rii shows the linear regression values for the protein 
standard curve. This standard curve is well within experimental error 
and was used as the basis for measuring all activity assays. 
48 
TABLE II 
Solutions: 
Reagent A: 
2% Na2co3 in 0.1 N NaOH 
Reagent B: 
0.5% Cuso
4 
• 5 H2o in 1.0% sodium potassium tartrate 
Reagent C: 
50.0 ml. of Reagent A are mixed with 1.0 ml. of Reagent B. 
This solution is discarded after one day. 
Reagent E: 
Dilute .Folin-Ciocalteau reagent 1:1 with water. 
Standard Solutions: 
The following standard solution concentrations were used to 
prepare the standard protein curve and were made from 
crystalline bovine serum albumin dissolved in water. The 
listed concentrations were contained in 0.7 ml. of solution. 
100 micrograms of crystalline bovine serum albumin I 0.7 ml. 
75 " 
so " 
25 " 
10 " 
5 " 
NOTE: All reagents were obtained from Sigma Chemical Company, St. 
Louis, Mo. 
Equipment: 
Bausch and Lomb "spectronic 20" 
vortex 
electric timer 
50 ml. beakers or Erlenmeyer flasks 
1 mi. pipettes 
5 ml. pipettes 
10 ml. pipettes 
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FIGURE I 
PROTEIN STANDARD CURVE 
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TABLE III 
LINEAR REGRESSION VALUES FOR PROTEIN STANDARD CQRVE 
X 
2.5 micrograms 
5.0 II 
10.0 II 
25.0 II 
so. 0 II 
75.0 II 
100 II 
THEORETICAL Y 
0.0035 
0.0065 
0.0124 
0.0302 
o. 0599 
0.0895 
0.1192 
a 0 = 0.0005 
a = 0.0012 1 
best fit (r2 ) 
s = 0.0008 
0 
s = 0.0017 y·x 
sl = 0 
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0.09987 
ACTUAL Y 
0.0052 
0.0068 
0.0126 
0.0288 
0.0574 
0.0921 
0.1188 
THIOCYANATE STANDARD CURVE FOR RHODANESE ACTIVITY 
Equipment and reagents used for the rhodanese assay are listed in 
Table IV. 
Figure II is the standard curve for the enzyme reaction product, 
thiocyanate, and shows absorbance (optical density, or O.D.} vs. concen-
tration. The points on the curve represent the best fit points derived 
by linear regression using the mean absorbance of each of the thiocyanate 
concentrations chosen. The standard deviation of the experimental values 
for each point is also shown. 
The following is the equation of the line derived by linear re-
gression. It was used to calculate all experimental thiocyanate 
concentrations. 
X =(Y .,. . 0028\ 90.90909 
383. 9J. I 
where_ 9-0.90909 = 5.0 (12.50) 
- .25 2.75 
factor obtained as follows: 
represents the dilution 
5.0 = total supernatant volume 
.25 = sample of supernatant volume measured 
12.50 = ml. of water added to each reaction vessel 
2.75 =total volume in reaction vessel. 
Table V shows the linear regression values for the thiocyanate 
standard curve. This standard curve is well within experimental error 
and was used as the basis for measuring all activity assays. 
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TABLE IV 
EQUIPMENT AND REAGENTS FOR RHODANESE ASSAY 
Solutions: 
0.0125 M Na S 0 
2 2 3 
0.025% serum bovine albumin (crystalline was used) 
0.125 M Na S 0 
2 2 3 
0.2 M NaH2Po4 (buffered to pH = 8.6) 
0.25 M NaCN 
\ j 
Ferric Nitrate reagent: 100 g Fe(N03) 3 ~9 H2o 
s.g. 1.40, and H2o to 1 liter 
38% formaldehyde 
+ 200 ml. HNO , 
3 
1:1 mixture of 0.0125 M Na S 0 and 0.025% serum bovine albumin 
2 2 3 
Standard Solutions: 
Equipment: 
0. 01 M NaSCN 
0.005 M NaSCN 
0.001 M NaSCN 
0.0005 M NaSCN 
Bausch and Loeb "spectronic 20" 
30° C water bath 
vortex 
electric timer 
25 ml. Erlenmeyer flasks and/or 20 ml. test tubes 
1 ml. pipettes 
5 ml. pipettes 
10 ml. pipettes 
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FIGURE II 
THIOCYANATE STANDARD CURVE 
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TABLE V 
LINEAR REGRESSION VALUES FOR THE THIOCYANATE STANDARD CURVE 
X Actual y Theoretical y 
- -
0000 mmole 0.0028 0000 
0.00010 " 0.0412 0.0419 
0.00025 " 0.0988 0.1076 
0.0005 " 0.1947 0.1858 
0.001 " 0.3867 0.3889 
a = 0.0028 
0 
al = 383.9122 
best fit (r2) .9982 
sl = 9.4567 
s 
0 = 
0.0049 
s = 0.0076 y·x 
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TISSUE ASSAY CALCULATIONS FOR RHODANESE AND PROTEIN 
The nine crude tissue supernatants (control mouse live~, kidney, 
muscle, and brain; and tumor-bea~ing mouse liver, kidney, muscle, brain 
and tumor) were assayed for rhodanese activity. Five different samples 
of each tissue type were assayed using the six incubation times (0, l, 
2, 4, 8, and 16 min.r plus a blank for each assay. The percent trans-
mission for each o:f these seven reaction vessels was recorded. This 
gave a total of 7 vessels X 5 assays ::: 35 individual readings plus 1 
protein determination for each assay = 40 readings for each of the nine 
tissues. With this data the following calculations were performed. 
1. Tlie percent transmissions were converted to optical density 
(O.D. or absorbance)_ using the formula O.D. ::: - log _ _.1.,___, 
% T 
for both protein and enzyme assays. 
This was done 
2. The O.D. values for the enzyme assays were then substituted 
into the best fit {linear regression} equation for the thiocyanate 
standard curve as Y, to obtain the X value, or mmoles of thiocyanate. 
Similarly, the O.D. value of each protein assay was substituted into the 
-best fit Uinear regression) equation for the protein standard curve as 
Y, and the X value, g protein, 'was determined. 
3. The g of protein value was converted to mg protein by 
dividing by 1000, and the mmole of thiocyanate value was converted to 
~mole of thiocyanate by multiplying by 1000. 
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4. Each micromole of thiocyanate value was divided by its co~re­
sponding protein value for:: that particular assay to give micromole 
thiocyanate produced per mg protein for each of the seven vessels for 
each assay. Note that this value, micromoles thiocyanate per mg pro-
tein is the measure of rhodanese activity for that assay time for that 
tissue. One rhodanese unit is defined as 1 micromole thiocyanate 
formed/mg protein/min. 
5. The mean of the five values for each reaction time for each 
tissue was det~rmined as well as the standard error or standard devia-
tion. If each assay represented a pooling of one particular tissue type 
but from several different animals (this included the assays for kidney, 
muscle, brain, and tumor tissuesl, the standard e~ror was determined. 
If each assay represented tissue from only one animal (liverL then the 
standard deviation was calculated. 
~ chart of the data for tumor-bearing mouse kidney is given in 
Table IV as an example. It shows the data from the five assays of the 
tissue and all calculated values as described above. Sample calcula-
tions using data from this tissue are given in Table VII, 
A chi square analysis was then performed in order to determine 
·whether or not a significant difference in rhodanese activity existed 
between: 
1. each tumo~-bea~ing mouse tissue and its cor~esponding 
control tissue 
2. the neoplastic tissue and each analyzed tumor-bearing 
rouse tissue. 
TABLE VI 
TUMOR-BEARING MOUSE KIDNEY DATA - A SAMPLE OF 
DATA COLLECTED AND COMPUTED FOR EACH SELECTED TISSUE 
vessel Column 1st 2nd 3rd 4th 5th Mean Standard 
Reaction Exp1an- Assay Assay Assay Assay Assay Error 
Time ation 
%T 85.5 100 93.3 99.5 100 
0 min. o. D. 0.0680 0 0.0301 0.0022 0 
pmo1e - 15.439 6.465 0 SCN 
units 1. 2860 0.5256 0 0.3623 .±. 0.2257 
%T 74.9 85.7 83.5 87.9 88.3 
1 min. o. D. 0.1255 0.0670 0.0783 0.0560 0.0540 
prno1e SCN 29.055 15.202 17.878 12.598 12.124 
units 2.4202 1.4426 1.4535 0.9388 0.8773 1.4285 + 0.2463 
%T 63.0 68.4 76.3 79.0 70.7 
2 min. 0. D. 0.2007 0.1649 0.1158 0.1024 0.1506 
-~le SCN 46.862 38.385 26.758 23.585 34.998 
units 3.9035 3.6425 2.1754 1. 7576 2.5326 2.8023 i. o. 3729 U1 
(X) 
%T 52.1 44.7 56.7 65.2 65.3 
4 min. o. D. 0.2832 0.3497 0.2464 0.1858 0.1851 
pmo1e SCN - 66.398 82.145 57.684 43.334 43.168 
units 5.5309 7.7951 4.6898 3.2293 3.1238 4.8738 + 0.7685 
TABLE VI CONTINUED 
Vessel Column 1st . 2nd 3rd 4th 5th Mean Standard 
Reaction Explan- Assay Assay Assay Assay Assay Error 
Time ation 
%T 25.8 25.2 32.8 61.5 45.7 
8 min. o. D. 0.5884 0.5986 0.4841 0.2111 0.3401 
-pmo1e SCN 138.668 141.083 113.970 49.325 79.871 
units 11.551 13.388 9.2659 3.6758 5. 7798 8.7321 ±. 1.6024 
%T 9.6 15.9 21.2 58.3 23.9 
16 min. o. D. 1.0177 0.7986 0.6737 0.2343 0.6216 
pmole SCN - 240.325 188.443 158.867 54.818 146.530 
units 20.002 17.882 12.916 4.0851 10.604 13.0978 ±. 2.5143 
%T 100 100 100 100 100 
blank o. D. i i i i i 
JmlOle SCN - i i i i i 
units i i i i i 
Protein %T 55.9 60.0 55.1 52.2 51.2 
Cone en- o. D. 0.2526 0.2218 0.2588 0.2823 0.2907 
tration mg protein 12.002 10.538 12.300 13.4195 13.8195 
U1 
1.0 
TABLE VII 
SAMPLE CALCULATIONS 
1. First, the % T was converted to absorbance (optical density 
oro. D.). 
eg. "0" time, assay #1, from TABLE VI. 
0. D. = ~ lo~ __ l_ Convert 85.5% to 0.855, then substitute. 
%T 
o. D. - log 1 
0.855 
O. D. = 0.680 
2. The 0. D. value was then substituted into the best fit 
eg. 
(linear regression) equation for the thiocyanate standard curve 
as Y, to obtain the X value, or mrnoles of thiocyanate. 
X = y - 0.0028 (90. 90909) 
383.91 
X = 0.680 - 0.0028 (90. 90909) 
383.91 
X = 0.015439 mmole thiocyanate 
3. This value was then converted to micromoles by multiplying by 1000. 
eg. 0.015439 X 1000 = 15.439 micromoles of thiocyanate 
4. Steps shown above were performed on the corresponding data for 
the protein assays. Then micromoles thiocyanate per mg protein 
was calculated for each vessel for each assay. See TABLE VI. 
Using the value calculated above in #3, divide by mg protein 
determined for assay #1. 
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TABLE VII - CONTINUED 
15.439 micromoles thiocyanate 
12.002 mg protein = 1.2860 micromoles thiocyanate/ 
mg protein 
(or 1.2860 rhodanese units) 
5. The mean was then determined by adding the micromoles thiocyanate 
per mg protein value (rhodanese unit value) for all five assays 
of a particular time and dividing by five. 
eg. The "2" min. time from TABLE VI = 3.9035 + 3.6425 + 2.1754 + 
1.7576 + 2.5326 = 14.0116 = 2.8023 micromoles thiocyanate per mg 
5 assays 
protein mean value or rhodanese units mean value or X. 
6. Standard error was then determined on values that represented 
means of means (tissue from more than one animal in each assay). 
eg. values from "2" min. column from TABLE VI. 
S- = X 
N~x. 2 
1 
2 N _ - ( N - 1) 
where: 
N = # of samples (here 5) 
Xi = sample value 
5(3.9035) 2 + (3.6425) 2 + (2.1754) 2 + (1.7576) 2 + 
52 (5-l) 
(2.5326) 2 - (3.9035 + 3.6425 + 2.1754 + 1.7576 + 2.5326) 2 
(denominator shown above) 
61 
TABLE VII - CONTINUED 
S;c = + 0. 3729 
The standard deviation was used on values that represented means 
of one value (when only one tissue was used in each assay). 
eg. 
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where: 
N = # of samples 
X = sample value 
GLASSWARE AND EQUIPMENT PREP~TION 
All glassware and equipment was soaked, then scrubbed in a solution 
of a detergent (Alconox, Alconox, Inc., N.Y., N.Y.r, rinsed twelve times 
in tap water, eight to ten times in distilled water, and six times in dis-
tilled deionized water. When clean and dry, glassware was protected from 
dust with a parafilm covering and stored until use . 
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